Summit Therapeutics Inc. (SMMT) Total Assets by Year
Summit Therapeutics Inc. closed fiscal year 2025 with $751.2M in total assets, $92.3M in total liabilities and $658.9M in shareholder equity. This represents an increase of 72.5% from the prior fiscal year. The table below carries 9 fiscal years, from 2018 to 2025, and the quarters Summit Therapeutics Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SMMT Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1910-K | FY1810-K |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $751.2M+72.5% | $435.6M+114.6% | $202.9M-69.4% | $664.2M+485.8% | $113.4M+10.6% | $102.5M+6.5% | $96.2M | $79.6M+1.7% | $78.2M |
| Total Liabilities | $92.3M+97.2% | $46.8M-62.6% | $125.3M-76.7% | $537.5M+1686.4% | $30.1M+30.6% | $23.0M+32.6% | $17.4M | $47.4M-42.7% | $82.7M |
| Total Equity | $658.9M+69.5% | $388.7M+400.4% | $77.7M-38.7% | $126.7M+52.1% | $83.3M+4.8% | $79.5M+0.7% | $78.9M | $32.2M+996.3% | -$3.6M |
SMMT Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $752.2M+132.1% | $647.9M+68.8% | $751.2M+72.5% | $261.7M-48.0% | $324.0M-5.2% | $383.8M+117.1% | $435.6M+114.6% | $502.9M+130.2% | $341.9M+44.0% | $176.8M-30.6% | $202.9M-69.4% | $218.5M+40.7% |
| Total Liabilities | $122.2M+89.2% | $101.9M+158.1% | $92.3M+97.2% | $69.5M+7.0% | $64.6M-56.0% | $39.5M-70.2% | $46.8M-62.6% | $64.9M-45.5% | $146.8M+24.6% | $132.6M+9.2% | $125.3M-76.7% | $119.1M+439.4% |
| Total Equity | $630.0M+142.8% | $545.9M+58.5% | $658.9M+69.5% | $192.3M-56.1% | $259.4M+33.0% | $344.3M+678.9% | $388.7M+400.4% | $437.9M+340.7% | $195.1M+63.1% | $44.2M-66.9% | $77.7M-38.7% | $99.4M-25.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Summit Therapeutics Inc. financials
Frequently Asked Questions
What was Summit Therapeutics Inc.'s total assets in fiscal year 2025?
Summit Therapeutics Inc. closed fiscal year 2025 with $751.2M in total assets, $92.3M in total liabilities and $658.9M in shareholder equity.
How fast is Summit Therapeutics Inc.'s total assets growing?
Summit Therapeutics Inc. (SMMT) total assets rose by 72.5% year over year, from $435.6M to $751.2M in fiscal year 2025.
How has Summit Therapeutics Inc.'s total assets changed over the years?
Across the 9 fiscal years this page covers, Summit Therapeutics Inc. (SMMT) total assets went from $78.2M in fiscal year 2018 to $751.2M in fiscal year 2025.
What was Summit Therapeutics Inc.'s total assets in the most recent quarter?
Summit Therapeutics Inc. (SMMT) reported $752.2M in total assets in Q2 2026. This represents an increase of 132.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Summit Therapeutics Inc. (SMMT) reported on that line in every period on record.